Zentiva Pharma UK Ltd
Supplier — contracts won
£2.7bnTotal value£2,651,931,922 across every award on file
6Awardspublished since 4 July 2024
Who buys from them
| Buyer | Awards | Value |
|---|---|---|
| NHS England | 6 | £2.7bn |
Every award on file
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 22 Jul 2024 | NHS Branded Medicines Tranche Framework for London and South of EnglandEast Midlands | NHS England | Sun Pharma UK Ltd +28 | £381.0m |
| 20 Feb 2025 | CM/TNS/24/5719 - NHS National Framework for the supply of PomalidomideEast Midlands | NHS England | Zentiva Pharma UK Ltd +4 | £17.1m |
| 30 Sep 2024 | NHS National Framework for Transition products commencing 1 October 2024East Midlands | NHS England | Thornton and Ross Ltd +11 | £16.2m |
| 14 Jan 2025 | CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025East Midlands | NHS England | Sun Pharma UK Ltd +5 | £9.9m |
Organisations are grouped by name, because the notices carry no identifier that appears on all of them. A body that publishes under two spellings will appear twice; two different companies with the same trading name will appear as one. Check the individual notices before drawing a conclusion.